Geriatric medicine

On this site you will find information about clinical trials in the field of geriatric medicine

You are here:

Clinical trials

In our capacity as a research institution, our goal is to develop and clinically test new therapies and treatments. Participation is voluntary and the trials do not affect our other diagnostic and therapeutic services.

All clinical trials we conduct are placebo-controlled. One group of patients receives the test treatment while another group is treated with a placebo.

In addition to this safeguard, trials are double-blind: neither the participants nor the persons administering the trial know who has been randomized to the test group or to the placebo group. This ensures impartiality and strengthens the quality of the results. Each trial includes a follow-up study.

Who can participate in trials?

A variety of criteria must be met for participation, including age, severity of the diagnosis and the general health of the participant. These checks are carried out on an individual basis.

For more information about forthcoming clinical studies, and to find out how you can take part, please contact us to arrange a consultation.

Pioneering new approaches

In this interview with German public broadcaster Deutsche Welle, the head of Geriatric Medicine at the Charité Dr. Peters discusses new approaches for treating Alzheimers. Watch the interview.


Clinical trials to participate in:



Publicly funded studies

SIMaMCI Prevention Study Phase IV

SIMaMCI Prevention Study Phase IV
Seeking: Patients with mild cognitive impairment (amnestic MCI)
Sponsor: BMBF
Now recruiting

DZNE Delcode observational study

DZNE Delcode observational study
Seeking: healthy control subjects, subjective memory complaints, patients with mild cognitive impairment, patients with mild Alzheimer's dementia, close relatives of patients with Alzheimer's disease.

Sponsor: German Center for Neurodegenerative Disease (DZNE)
Now recruiting

DZNE DESCRIBE-FTD observational study

DZNE DESCRIBE-FTD observational study
Seeking
healthy control subjects; patients with a variant of frontotemporal lobar degeneration (PPA, PNFA, LPA, semantic dementia, behavioural FTLD)

Sponsor: German Center for Neurodegenerative Disease (DZNE)
Now recruiting

Studies funded in co-operation with industry partners:

PharmatrophiX Therapy trial Phase I-II

PharmatrophiX Therapy trial Phase I-II
Seeking: Mild to moderate Alzheimer's disease
Sponsor: PharmatrophiX
Now recruiting

To top


Clinical trials enquiries

Steglitz on CBF

+49 30 450 517 688

+49 30 450 517 977

Buch on CBB– ECRC

+49 30 450 540 077

+49 30 450 540 997

Division of Geriatric Medicine - Patient Information: